Danaher to acquire Abcam for $24.00 per Share

Go back to Danaher to acquire Abcam for $24.00 per Share

Stifel on Danaher (DHR): 'Abcam Acquisition Is a Good Fit; EPS Accretion Modest, But Valuation Reasonable In the Context of Peer'

August 28, 2023 10:36 AM EDT

Stifel analyst Daniel Arias reiterated a Hold rating and $240.00 price target on Danaher (NYSE: DHR).

The analyst comments "This morning DHR announced that it has entered into a definitive agreement to acquire Abcam for $24/share in cash for a total enterprise value of ~$5.7B including assumed indebtedness and net of acquired cash, which represents a roughly 32x EBITDA multiple. The deal is expected to be funded with cash on hand and commercial paper. Abcam is expected to operate as a... More